Recombinant Human Toll-like receptor 10 (TLR10), partial

What is the genomic location of human TLR10 and how does it relate to other TLRs?

Human TLR10 shares a common locus with TLR1 and TLR6 on chromosome 4p14. This genomic clustering reflects their evolutionary relationship and structural similarities. Phylogenetic analysis indicates that TLR10 is closely related to TLR1 and TLR6, likely emerging from a common TLR1/6/10 ancestor that duplicated to produce a TLR1/6 precursor and TLR10 . This genomic organization is preserved across species that maintain functional TLR10 genes, suggesting important evolutionary conservation of this receptor family.

What is known about TLR10's protein structure?

TLR10 consists of three major domains: an extracellular domain (ECD) responsible for ligand recognition, a single-pass transmembrane (TM) helix, and an intracellular TIR (Toll/Interleukin-1 receptor) domain that mediates downstream signaling . The ECD contains multiple leucine-rich repeat motifs that form a horseshoe-like structure, similar to other TLRs. TLR10 is heavily N-glycosylated, with human TLR10 containing seven potential sites for N-glycosylation . While crystal structures exist for the TIR domain, the complete structure of TLR10 has not been experimentally determined, necessitating computational modeling approaches to understand its full-length architecture .

What are the proposed functions of TLR10?

TLR10 exhibits both pro-inflammatory and anti-inflammatory properties, though its precise functions remain incompletely characterized . Unlike other TLRs that primarily drive inflammatory responses, emerging evidence suggests TLR10 may play a unique immunoregulatory role. It can form homodimers and heterodimers with TLR1 and TLR2, suggesting potential functional interactions with these receptors . TLR10 directly associates with the adapter protein MyD88, indicating its capacity to activate gene transcription through canonical TLR signaling pathways . The restricted expression pattern of TLR10 in specific immune cell populations further suggests specialized functions in immune regulation.

Which cell types express TLR10?

TLR10 exhibits a highly restricted expression pattern compared to other TLRs. It is predominantly expressed in:

• B cell lines and primary B cells from peripheral blood

• Plasmacytoid dendritic cells (pDCs) from tonsil

• CD1a+ dendritic cell subset derived from CD34+ progenitor cells that resemble Langerhans cells

Notably, resting B cells stimulated with anti-μ and anti-CD40 antibodies or with Staphylococcus aureus Cowan I bacteria show increased mRNA expression of TLR10, suggesting its regulation during B cell activation . This restricted expression pattern differs from TLR1 and TLR6, despite their genomic proximity, indicating unique functions for TLR10 in specific immune cell populations.

How can researchers detect TLR10 expression in experimental systems?

Detection of TLR10 requires specific methodological approaches:

• RNA detection: Quantitative RT-PCR using TLR10-specific primers can measure mRNA expression levels. This approach was used to identify TLR10 upregulation in stimulated B cells .

• Protein detection: Western blotting with anti-TLR10 antibodies can detect the protein, which appears as a highly N-glycosylated protein. Researchers should be aware that post-translational modifications, particularly N-glycosylation, may affect antibody recognition and apparent molecular weight .

• Flow cytometry: Fluorescently-labeled antibodies against TLR10 can identify TLR10-expressing cells in heterogeneous populations like peripheral blood mononuclear cells.

• Immunohistochemistry: This can be used to visualize TLR10 expression in tissue sections, which has helped identify TLR10 in specific cell subsets like plasmacytoid dendritic cells in tonsil tissue .

What is known about TLR10 signaling pathways?

Studies have characterized regions in the TIR domain of TLR10 that are essential for activation of inflammatory cytokine promoters . Computational modeling and dynamic network analysis suggest that TLR10 may exist in different conformational states - an "open form" that represents the functional state and a "closed form" that may represent the apo (unbound) state . Despite these insights, the complete signaling pathway remains to be fully elucidated.

How does TLR10 interact with other TLRs?

TLR10 demonstrates both homodimerization and heterodimerization capabilities:

• Homodimerization: TLR10 can form dimers with itself, with binding affinity measurements showing approximately 100% efficiency for homodimer formation .

• Heterodimerization with TLR1: TLR10/TLR1 heterodimers form with approximately 87% binding affinity compared to homodimers .

• Heterodimerization with TLR2: TLR10/TLR2 complexes form with approximately 80% binding affinity . Given that TLR1 and TLR6 function as co-receptors for TLR2, this suggests TLR10 may similarly modulate TLR2 function.

These interactions were detected through co-immunoprecipitation experiments, revealing the capacity of TLR10 to engage with other TLRs despite its unique expression pattern and functional properties .

What methods are used to produce recombinant human TLR10?

Production of recombinant human TLR10 typically involves:

• Expression systems: Mammalian cell expression systems (e.g., HEK293 cells) are preferred for proper post-translational modifications, particularly N-glycosylation which is extensive in TLR10 .

• Expression vectors: Vectors containing the partial or complete TLR10 coding sequence, often with epitope tags (e.g., FLAG, His) to facilitate purification and detection.

• Domain-specific constructs: Researchers may express specific domains (ECD, TIR) separately for structural or functional studies. For instance, recombinant CD4-TLR10 fusion proteins have been used to demonstrate MyD88 association .

• Purification strategies: Affinity chromatography based on epitope tags followed by size exclusion chromatography to ensure homogeneity.

• Quality control: SDS-PAGE, Western blotting, and mass spectrometry to confirm protein identity, glycosylation status, and purity.

What approaches have been used to identify potential TLR10 ligands?

Despite being considered an orphan receptor, several approaches have been employed to identify potential TLR10 ligands:

• Computational modeling and docking: Structural models of TLR10-ECD have been used to predict potential ligand binding sites and interaction with candidate molecules like dsRNA .

• Reporter assays: Cells expressing TLR10 linked to reporter systems (e.g., NF-κB-driven luciferase) can be screened with candidate ligands.

• Constitutively active constructs: Fusion of the TLR10 TIR domain with dimerization domains can create constitutively active receptors that signal independently of ligand binding, allowing assessment of downstream signaling pathways .

• Co-immunoprecipitation: This technique has been used to identify protein-protein interactions, including TLR10's association with MyD88 and other TLRs .

• Binding studies: Direct binding of potential ligands to recombinant TLR10-ECD can be assessed using techniques like surface plasmon resonance or isothermal titration calorimetry.

How can researchers model the structure of full-length TLR10?

Given the absence of a complete experimental structure for TLR10, computational modeling approaches have been employed:

• Homology modeling: Using structures of related TLRs as templates. For example, the TLR10-ECD has been modeled based on TLR1, TLR2, and TLR3 structures to generate different conformational models (closed, semi-open, semi-closed, and open) .

• Domain assembly: Individual domains (ECD, TM, TIR) are modeled separately and then assembled into full-length models. The TIR domain can be based on its crystal structure, while the TM domain is typically modeled as an alpha-helix .

• Protein-protein docking: Used to predict dimer interfaces for TLR10 homodimers or heterodimers with other TLRs .

• Molecular dynamics simulations: These simulations in membrane-aqueous environments assess the stability and dynamics of the modeled structures, revealing global motions of the ECD and TIR domains relative to the membrane .

• Network analysis: Dynamic network analysis can identify key residues and interactions that differentiate functional states of the receptor .

What disease associations have been identified for TLR10 polymorphisms?

TLR10 genetic variations have been associated with multiple diseases:

• Autoimmune diseases: Rheumatoid arthritis (RA) and Crohn's disease have shown associations with TLR10 polymorphisms .

• Infectious diseases: Tuberculosis, influenza, HIV, and Helicobacter pylori infections show links to TLR10 genetic variations .

• Cancer: Multiple studies have connected TLR10 polymorphisms with cancer risk:

  • The rs11466653 SNP (Met326Thr) was found in 87.2% of papillary thyroid carcinoma patients, suggesting increased risk .

  • TLR10 variations have been linked to Non-Hodgkin lymphoma (NHL) .

  • Conversely, TLR10 rs11096955 (Ile369Leu) and rs11096957 (Asn241His) were associated with reduced prostate cancer risk .

• Other conditions: IgA Nephropathy (associated with rs1004195 SNP), aspergillosis, allergenic stem cell transplantation, bladder and nasopharyngeal carcinomas have all shown associations with TLR10 polymorphisms .

How can researchers investigate the functional consequences of TLR10 polymorphisms?

Several methodological approaches can assess the impact of TLR10 polymorphisms:

• Site-directed mutagenesis: Introduction of specific polymorphisms into recombinant TLR10 expression constructs.

• Cell-based functional assays: Comparing wild-type and polymorphic variants for:

  • Protein expression and localization

  • Dimerization capacity with self or other TLRs

  • MyD88 recruitment

  • Activation of downstream signaling pathways (NF-κB, MAP kinases)

  • Cytokine production

• Structural modeling: Computational approaches to predict how polymorphisms alter protein structure, ligand binding, or dimerization interfaces .

• Patient-derived cells: Comparing TLR10 function in cells from individuals with different genotypes.

• Population studies: Case-control studies examining the frequency of specific polymorphisms in disease versus healthy populations, as conducted for papillary thyroid carcinoma and IgA nephropathy .

Why is there no functional mouse homologue of TLR10?

The absence of a functional TLR10 in mice represents a significant challenge for researchers using mouse models. Key findings explain this evolutionary quirk:

• Genomic analysis: While the mouse genome contains a TLR10 gene at the same locus as TLR1 and TLR6 (similar to humans and rats), the mouse TLR10 gene is non-functional .

• Disruptive elements: The mouse TLR10 gene contains numerous gaps, insertions, and phase changes. Most critically, the TIR domain (essential for signaling) has been replaced by a retrovirus-like sequence .

• Evolutionary timing: This disruption likely occurred early in mouse evolution, as diverse mouse strains including wild-derived strains (CAST/Ei and SPRET/Ei) as well as laboratory strains all contain similar vestigial TLR10 sequences .

• PCR verification: Studies amplified and sequenced genomic DNA from nine unrelated mouse strains using primers designed for the signal peptide and transmembrane domains, confirming the universal disruption of TLR10 across mouse lineages .

What alternative animal models can be used to study TLR10 function?

Given the absence of functional TLR10 in mice, researchers must consider alternative approaches:

How do open and closed conformations of TLR10 relate to its function?

Computational modeling studies have identified multiple conformational states of TLR10:

• Structural variants: Four different models of TLR10-ECD have been proposed based on templates from other TLRs: 'closed-model' (based on TLR1 homodimer), 'semi-open-model' (based on TLR2 homodimer), 'semi-closed-model' (based on TLR2-TLR1 heterodimer), and 'open-model' (based on TLR3 homodimer) .

• Energetic analysis: The 'closed form' model appears energetically more favorable than the 'open form' model in simulation studies .

• Functional significance: Dynamic network analysis suggests that the 'open form' model may represent the functional form that can interact with ligands, while the 'closed form' model likely represents the apo (unbound) state of TLR10 .

• Conformational transitions: The mechanisms driving transitions between these states remain poorly understood but likely involve ligand binding and interaction with other TLRs.

Researchers investigating TLR10 conformations should consider molecular dynamics simulations in membrane environments to evaluate the stability and transitions between these conformational states.

What is the potential relationship between TLR10's anti-inflammatory properties and its evolutionary conservation?

TLR10 presents a fascinating evolutionary puzzle:

• Unique immunoregulatory role: Unlike most TLRs that are primarily pro-inflammatory, TLR10 appears to have anti-inflammatory properties in some contexts .

• Selective pressure: The preservation of TLR10 across many mammalian species (except mice) suggests important biological functions under evolutionary pressure.

• Research approaches: Investigators can address this question through:

  • Comparative genomics across species that maintain functional TLR10

  • Analysis of selective pressure on different TLR10 domains

  • Identification of conserved versus variable regions that might relate to specialized functions

  • Functional studies in different species to determine conservation of anti-inflammatory properties

Understanding this evolutionary aspect may provide insights into TLR10's unique role in immune regulation and the balance between pro- and anti-inflammatory responses.

How might the interaction between TLR10 and dsRNA contribute to its function?

Recent evidence suggests potential interaction between TLR10 and double-stranded RNA (dsRNA):

• Structural modeling: Computational studies have modeled the binding of dsRNA to TLR10 using defined and blind docking approaches .

• Differential binding: Simulations indicate differential binding of dsRNA to the protomers of TLR10, which could provide insights into ligand dissociation mechanisms .

• Research directions: Scientists interested in this interaction should consider:

  • Direct binding assays between recombinant TLR10-ECD and various dsRNA structures

  • Competitive binding studies with other nucleic acid-sensing TLRs

  • Mutational analysis of predicted RNA binding sites

  • Functional assays measuring signaling responses to different RNA ligands

  • Comparative analysis with TLR3, which is a well-characterized dsRNA sensor

This potential interaction opens new avenues for understanding TLR10's role in antiviral responses and RNA sensing.